Chris Boston

Chris Boston has gained extensive work experience in the field of scientific research and development. Chris started their career as a Research Associate at Indiana University in 2003, where they focused on studying chemokine/receptor complexes. During their time there, they completed their thesis titled "Towards a model of chemokine/receptor complexes: complementation of chimeric receptors and mutant chemokines." This involved cloning and replacing extracellular regions of the chemokine receptor CCR3 with those of the related chemokine receptor CCR2.

In 2009, Chris joined sanofi-aventis as a Scientist I, working under the supervision of Dietmar Hoffman. Their responsibilities included cloning genes via PCR for various research projects related to the discovery and development of therapeutic drugs. Within the company, they received cloning requests and completed the projects within 2-4 weeks, utilizing the Gateway System, the In Fusion system, or restriction enzymes.

In 2010, Chris moved to Percivia and took on the role of Associate Scientist II. Under the supervision of Robert Lu, they performed transfection of PER.C6® cells with DNA plasmids to produce biotherapeutics. This involved using recombinant protein sequences and transfecting the cells with the plasmids.

After working at Percivia, Chris joined Pfizer in 2012 as a Scientist I. During their tenure, they played an important role in the company's scientific research, although specific details about their responsibilities were not provided.

Most recently, Chris has been working at Scholar Rock since 2015. Chris started as a Senior Associate Scientist and later moved up to the position of Principal Associate Scientist in July 2016. Unfortunately, no information about the nature of their work at Scholar Rock was provided.

Overall, Chris Boston has accumulated a diverse range of experience in scientific research, particularly in areas such as cloning, transfection, and biotherapeutics production.

Chris Boston obtained a Bachelor of Science (BS) degree with a major in Biology, General and a minor in Chemistry from Albany State University, attending from 1997 to 2002. Later, Chris pursued a Master's degree in Biochemistry from Indiana University Bloomington, from 2002 to 2008.